아시아태평양의 프리필드 시린지 시장 예측(2030년) : 지역별 분석 - 유형, 소재, 디자인, 용도, 유통 채널별

The Asia Pacific prefilled syringe market was valued at US$ 1,225.22 million in 2022 and is expected to reach US$ 2,820.57 million by 2030; it is estimated to register a CAGR of 11.0% from 2022 to 2030.

Strategic Initiatives by Market Players Fuel Asia Pacific Prefilled Syringe Market

Various market players focus on product launches or strategic collaborations for the development of advanced products that help in the treatment of chronic disorders with ease. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below:

In April 2023, Delta Med Group partnered with DBM, a leading manufacturer of prefilled syringes. Delta Med Group and DBM will expand their portfolio, profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership will generate significant synergies and boost the growth trajectory of the combined entity. In June 2022, WuXi Biologics launched a drug product facility in China for prefilled syringes. The new facility has PFS capacity of 17 million units per year. The maximum filling speed can reach 400 PFSmin to support the manufacturing of 17 million syringes of drug products every year. In January 2022, Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd., received approval for UniSafe 1 ml safety device for prefilled syringes as a combination product in Asia. In March 2021, SK bioscience launched a new shingles vaccine called 'SKYZoster(R) Ini.' The newly introduced prefilled syringe type SKYZoster can be administered more conveniently than the current intramuscular injection type in which water for injection and freeze-dried vaccine are mixed and then transferred back into the syringe. Thus, a surge in product launches and strategic collaborations is likely to create considerable growth opportunities for the prefilled syringes market in the future.

Asia Pacific Prefilled Syringe Market Overview

The Asia Pacific prefilled syringes market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2022, and India is expected to have a significant growth rate in the market during 2022-2030. The market growth in these countries is attributed to the advancements in treatment of diabetes that have resulted in rising injectable therapies. Moreover, Chinese Diabetes Society has taken a lead in insulin injection education over the past decade for the treatment of diabetes. Therefore, with high awareness and usability of prefilled syringes intended for diabetes population in China, the market for prefilled syringes will grow subsequently in the near future.

Asia Pacific Prefilled Syringe Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Prefilled Syringe Market Segmentation

The Asia Pacific prefilled syringe market is segmented based on type, material, design, application, distribution channel, and country.

Based on type, the Asia Pacific prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger Asia Pacific prefilled syringe market share in 2022.

In terms of material, the Asia Pacific prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger Asia Pacific prefilled syringe share in 2022.

Based on designs, the Asia Pacific prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held a larger Asia Pacific prefilled syringe share in 2022.

In terms of application, the Asia Pacific prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held the largest Asia Pacific prefilled syringe share in 2022.

By distribution channel, the Asia Pacific prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held the largest Asia Pacific prefilled syringe market share in 2022.

Based on country, the Asia Pacific prefilled syringe market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific prefilled syringe market in 2022.

B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Gerresheimer AG, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG are some of the leading companies operating in the Asia Pacific prefilled syringe market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Prefilled Syringe Market - Key Industry Dynamics

• 4.1 Market Drivers
  • 4.1.1 Increasing Prevalence of Chronic Disorders
  • 4.1.2 Growing Adoption of Self-Injecting Parenteral Devices
• 4.2 Market Restraints
  • 4.2.1 Increasing Product Recalls
• 4.3 Market Opportunities
  • 4.3.1 Strategic Initiatives by Market Players
• 4.4 Future Trends
  • 4.4.1 Ongoing Innovation in Prefilled Syringes
• 4.5 Impact Analysis

5. Prefilled Syringe Market - Asia Pacific Market Analysis

• 5.1 Asia Pacific Prefilled Syringe Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 - by Type

• 6.1 Overview
• 6.2 Asia Pacific Prefilled Syringe Market Revenue Share, by Type 2022 & 2030 (%)
• 6.3 Disposable Prefilled Syringes
  • 6.3.1 Overview
  • 6.3.2 Disposable Prefilled Syringes: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Reusable Prefilled Syringes
  • 6.4.1 Overview
  • 6.4.2 Reusable Prefilled Syringes: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 - by Material

• 7.1 Overview
• 7.2 Asia Pacific Prefilled Syringe Market Revenue Share, by Material 2022 & 2030 (%)
• 7.3 Glass Prefilled Syringes
  • 7.3.1 Overview
  • 7.3.2 Glass Prefilled Syringes: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Plastic Prefilled Syringes
  • 7.4.1 Overview
  • 7.4.2 Plastic Prefilled Syringes: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 - by Design

• 8.1 Overview
• 8.2 Asia Pacific Prefilled Syringe Market Revenue Share, by Design 2022 & 2030 (%)
• 8.3 Single Chamber
  • 8.3.1 Overview
  • 8.3.2 Single Chamber: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Multi-chamber
  • 8.4.1 Overview
  • 8.4.2 Multi-chamber: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 - by Application

• 9.1 Overview
• 9.2 Asia Pacific Prefilled Syringe Market Revenue Share, by Application 2022 & 2030 (%)
• 9.3 Cancer
  • 9.3.1 Overview
  • 9.3.2 Cancer: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Diabetes
  • 9.4.1 Overview
  • 9.4.2 Diabetes: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Autoimmune Diseases
  • 9.5.1 Overview
  • 9.5.2 Autoimmune Diseases: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Infectious Diseases
  • 9.6.1 Overview
  • 9.6.2 Infectious Diseases: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 9.7 Others
  • 9.7.1 Overview
  • 9.7.2 Others: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 - by Distribution Channel

• 10.1 Overview
• 10.2 Asia Pacific Prefilled Syringe Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
• 10.3 Hospital Pharmacies
  • 10.3.1 Overview
  • 10.3.2 Hospital Pharmacies: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 10.4 Retail Pharmacies
  • 10.4.1 Overview
  • 10.4.2 Retail Pharmacies: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)
• 10.5 Online Channels
  • 10.5.1 Overview
  • 10.5.2 Online Channels: Asia Pacific Prefilled Syringe Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Prefilled Syringe Market - Country Analysis

• 11.1 Asia Pacific Prefilled Syringes Market, Revenue and Forecast to 2030
  • 11.1.1 Overview
  • 11.1.2 Asia Pacific Prefilled Syringes Market, by Country
    • 11.1.2.1 China
      • 11.1.2.1.1 Overview
      • 11.1.2.1.2 China Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.1.3 China: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
      • 11.1.2.1.4 China: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
      • 11.1.2.1.5 China: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
      • 11.1.2.1.6 China: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
      • 11.1.2.1.7 China: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 11.1.2.2 Japan
      • 11.1.2.2.1 Overview
      • 11.1.2.2.2 Japan Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.2.3 Japan: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
      • 11.1.2.2.4 Japan: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
      • 11.1.2.2.5 Japan: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
      • 11.1.2.2.6 Japan: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
      • 11.1.2.2.7 Japan: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 11.1.2.3 India
      • 11.1.2.3.1 Overview
      • 11.1.2.3.2 India Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.3.3 India: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
      • 11.1.2.3.4 India: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
      • 11.1.2.3.5 India: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
      • 11.1.2.3.6 India: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
      • 11.1.2.3.7 India: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 11.1.2.4 Australia
      • 11.1.2.4.1 Overview
      • 11.1.2.4.2 Australia Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.4.3 Australia: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
      • 11.1.2.4.4 Australia: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
      • 11.1.2.4.5 Australia: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
      • 11.1.2.4.6 Australia: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
      • 11.1.2.4.7 Australia: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 11.1.2.5 South Korea
      • 11.1.2.5.1 Overview
      • 11.1.2.5.2 South Korea Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.5.3 South Korea: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
      • 11.1.2.5.4 South Korea: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
      • 11.1.2.5.5 South Korea: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
      • 11.1.2.5.6 South Korea: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
      • 11.1.2.5.7 South Korea: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 11.1.2.6 Rest of Asia Pacific
      • 11.1.2.6.1 Overview
      • 11.1.2.6.2 Rest of Asia Pacific Prefilled Syringes Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.6.3 Rest of Asia Pacific: Prefilled Syringes Market, by Type, 2020-2030 (US$ Million)
      • 11.1.2.6.4 Rest of Asia Pacific: Prefilled Syringes Market, by Material, 2020-2030 (US$ Million)
      • 11.1.2.6.5 Rest of Asia Pacific: Prefilled Syringes Market, by Design, 2020-2030 (US$ Million)
      • 11.1.2.6.6 Rest of Asia Pacific: Prefilled Syringes Market, by Application, 2020-2030 (US$ Million)
      • 11.1.2.6.7 Rest of Asia Pacific: Prefilled Syringes Market, by Distribution Channel, 2020-2030 (US$ Million)

12. Industry Landscape

• 12.1 Overview
• 12.2 Organic Developments
  • 12.2.1 Overview
• 12.3 Inorganic Developments
  • 12.3.1 Overview

13. Company Profiles

• 13.1 B Braun SE
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Shandong Weigao Group Medical Polymer Co Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Gerresheimer AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Schott AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Nipro Corp
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 Becton Dickinson and Co
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Baxter International Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 Terumo Corp
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 Ypsomed Holding AG
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

• 14.1 About Us
• 14.2 Glossary of Terms